131 related articles for article (PubMed ID: 32307259)
1. Optimization and biological evaluation of imidazopyridine derivatives as a novel scaffold for γ-secretase modulators with oral efficacy against cognitive deficits in Alzheimer's disease model mice.
Sekioka R; Honda S; Akashiba H; Yarimizu J; Mitani Y; Yamasaki S
Bioorg Med Chem; 2020 Jun; 28(11):115455. PubMed ID: 32307259
[TBL] [Abstract][Full Text] [Related]
2. Discovery of N-ethylpyridine-2-carboxamide derivatives as a novel scaffold for orally active γ-secretase modulators.
Sekioka R; Honda S; Honjo E; Suzuki T; Akashiba H; Mitani Y; Yamasaki S
Bioorg Med Chem; 2020 Jan; 28(1):115132. PubMed ID: 31767402
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel scaffolds for γ-secretase modulators without an arylimidazole moiety.
Sekioka R; Honjo E; Honda S; Fuji H; Akashiba H; Mitani Y; Yamasaki S
Bioorg Med Chem; 2018 Jan; 26(2):435-442. PubMed ID: 29249626
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators.
Takai T; Hoashi Y; Tomata Y; Morimoto S; Nakamura M; Watanabe T; Igari T; Koike T
Bioorg Med Chem Lett; 2015 Oct; 25(19):4245-9. PubMed ID: 26298496
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.
Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N
Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.
Chen JJ; Qian W; Biswas K; Yuan C; Amegadzie A; Liu Q; Nixey T; Zhu J; Ncube M; Rzasa RM; Chavez F; Chen N; DeMorin F; Rumfelt S; Tegley CM; Allen JR; Hitchcock S; Hungate R; Bartberger MD; Zalameda L; Liu Y; McCarter JD; Zhang J; Zhu L; Babu-Khan S; Luo Y; Bradley J; Wen PH; Reid DL; Koegler F; Dean C; Hickman D; Correll TL; Williamson T; Wood S
Bioorg Med Chem Lett; 2013 Dec; 23(23):6447-54. PubMed ID: 24139583
[TBL] [Abstract][Full Text] [Related]
7. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of piperazine derivatives as a novel class of γ-secretase modulators that selectively lower Aβ₄₂ production.
Takai T; Koike T; Honda E; Kajita Y; Nakamura M; Morimoto S; Hoashi Y; Kamata M; Watanabe T; Igari T; Terauchi J
Bioorg Med Chem; 2015 May; 23(9):1923-34. PubMed ID: 25842363
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and Toxicological Properties of the Potent Oral
Wagner SL; Rynearson KD; Duddy SK; Zhang C; Nguyen PD; Becker A; Vo U; Masliah D; Monte L; Klee JB; Echmalian CM; Xia W; Quinti L; Johnson G; Lin JH; Kim DY; Mobley WC; Rissman RA; Tanzi RE
J Pharmacol Exp Ther; 2017 Jul; 362(1):31-44. PubMed ID: 28416568
[TBL] [Abstract][Full Text] [Related]
10. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators (Part 2).
Takai T; Koike T; Nakamura M; Kajita Y; Yamashita T; Taya N; Tsukamoto T; Watanabe T; Murakami K; Igari T; Kamata M
Bioorg Med Chem; 2016 Jul; 24(14):3192-206. PubMed ID: 27255179
[TBL] [Abstract][Full Text] [Related]
12. Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.
Zettl H; Ness J; Hähnke V; Beher D; Jumpertz T; Saric A; Baumann K; Pietrzik CU; Bulic B; Schneider G; Weggen S
ACS Chem Biol; 2012 Sep; 7(9):1488-95. PubMed ID: 22725102
[TBL] [Abstract][Full Text] [Related]
13. Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivo.
Huang Y; Li T; Eatherton A; Mitchell WL; Rong N; Ye L; Yang XJ; Jin S; Ding Y; Zhang J; Li Y; Wu Y; Jin Y; Sang Y; Cheng Z; Browne ER; Harrison DC; Hussain I; Wan Z; Hall A; Lau LF; Matsuoka Y
Neuropharmacology; 2013 Jul; 70():278-86. PubMed ID: 23485401
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of a novel and potent γ-secretase modulator as a therapeutic option for the treatment of Alzheimer's disease.
Murakami K; Watanabe T; Koike T; Kamata M; Igari T; Kondo S
Brain Res; 2016 Feb; 1633():73-86. PubMed ID: 26707977
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
[TBL] [Abstract][Full Text] [Related]
16. Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators.
Gerlach K; Hobson S; Eickmeier C; Groß U; Braun C; Sieger P; Garneau M; Hoerer S; Heine N
Bioorg Med Chem; 2018 Jul; 26(12):3227-3241. PubMed ID: 29735425
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators.
Rynearson KD; Buckle RN; Herr RJ; Mayhew NJ; Chen X; Paquette WD; Sakwa SA; Yang J; Barnes KD; Nguyen P; Mobley WC; Johnson G; Lin JH; Tanzi RE; Wagner SL
Bioorg Med Chem; 2020 Nov; 28(22):115734. PubMed ID: 33007551
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.
Bischoff F; Berthelot D; De Cleyn M; Macdonald G; Minne G; Oehlrich D; Pieters S; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter I; Zaja M; Borghys H; Masungi C; Mercken M; Gijsen HJ
J Med Chem; 2012 Nov; 55(21):9089-106. PubMed ID: 22650177
[TBL] [Abstract][Full Text] [Related]
19. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
[TBL] [Abstract][Full Text] [Related]
20. Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects.
Toyn JH; Boy KM; Raybon J; Meredith JE; Robertson AS; Guss V; Hoque N; Sweeney F; Zhuo X; Clarke W; Snow K; Denton RR; Zuev D; Thompson LA; Morrison J; Grace J; Berisha F; Furlong M; Wang JS; Lentz KA; Padmanabha R; Cook L; Wei C; Drexler DM; Macor JE; Albright CF; Gasior M; Olson RE; Hong Q; Soares HD; AbuTarif M; Ahlijanian MK
J Pharmacol Exp Ther; 2016 Jul; 358(1):125-37. PubMed ID: 27189974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
